Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for thumb intrinsic muscle spasticity in children with cerebral palsy
ACTRN12606000492550Phase 3Recruiting
- Sponsor
- Dr Lisa Copeland
- Start
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cerebral palsy (CP) comparing Botulinum toxin A + casting + home therapy + splinting with Saline comparator + casting + home therapy + splinting (2 arms). Primary endpoint: Goal Attainment Scaling. Started Nov 2006; status: recruiting.
02
Drugs
botulinum toxin type Asaline
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on ACTRN12606000492550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000492550.